New isolated nucleic acid comprising a nucleotide sequence of a bacterial replicon centromere, useful for treating infection caused by Burkholderia and glanders and melioidosis

Isolated nucleic acid (I) comprising a nucleotide sequence of a bacterial replicon centromere, is new. Independent claims are included for: (1) vector comprising one or more nucleic acids; and (2) antibacterial composition comprising (I) and/or the vector, in combination with a carrier. ACTIVITY : A...

Full description

Saved in:
Bibliographic Details
Main Authors PASTA FRANCK, LANE HERBERT EDWIN DAVID, PASSOT FANNY, MARIE
Format Patent
LanguageEnglish
French
Published 14.01.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Isolated nucleic acid (I) comprising a nucleotide sequence of a bacterial replicon centromere, is new. Independent claims are included for: (1) vector comprising one or more nucleic acids; and (2) antibacterial composition comprising (I) and/or the vector, in combination with a carrier. ACTIVITY : Antibacterial. MECHANISM OF ACTION : None given. La présente invention concerne un acide nucléique isolé comprenant la séquence nucléotidique d'un centromère de réplicon bactérien ou un fragment de celle-ci pour son utilisation comme médicament.
Bibliography:Application Number: FR20090054782